CANY
ELAN icon

Caxton Associates (New York)’s Elanco Animal Health ELAN Stock Holding History

Caxton Associates (New York)’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,485
Closed -$240K – 543
2023
Q1 		$240K Buy
+25,485
New +$301K 0.04% 389
2022
Q4 		– Sell
-12,850
Closed -$159K – 499
2022
Q3 		$159K Buy
+12,850
New +$225K 0.02% 425

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Associates (New York)'s ELAN Position: Q2 2023 in Review

Caxton Associates (New York) sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 25,485 shares — an estimated $240K sold.

Caxton Associates (New York) first reported a position in ELAN in Q3 2022 and held it in 2 quarters. The position peaked at $240K in Q1 2023. 351 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Caxton Associates (New York) reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 25,485 Elanco Animal Health shares in Q2 2023, an estimated $240K.
  • Caxton Associates (New York) first reported a position in Elanco Animal Health in Q3 2022 and held it in 2 quarters.
  • Caxton Associates (New York)'s Elanco Animal Health position peaked at $240K in Q1 2023.
  • 351 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.